NCT02749721View on ClinicalTrials.gov

The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Major Depressive Disorder
Interventions
DRUG

vortioxetine

Open-label vortioxetine

Trial Locations (2)

60076

Rush University Medical Center, Skokie

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

ElMindA Ltd
All Listed Sponsors
collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

collaborator

ElMindA Ltd

INDUSTRY

lead

Rush University Medical Center

OTHER

NCT02749721 - The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter